Evidence map›Paper›PMID 30700599›Full record

ArticleJournal of virology2019

Rare Detection of Antiviral Functions of Polyclonal IgA Isolated from Plasma and Breast Milk Compartments in Women Chronically Infected with HIV-1.

Matthew Zirui Tay, Erika L Kunz, Aaron Deal, Lu Zhang, Kelly E Seaton, Wes Rountree, Joshua A Eudailey, Jack Heptinstall, Michael D McRaven, Edgar Matias and 11 more

Open access · hybridAbstract read
In one paragraph

Article in Journal of virology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 20 citations in OpenAlex.

  1. Unique Kinetics of the Human Milk Antibody Response to JYNNEOS Vaccine for Prevention of Monkey Pox: A Case Study.Breastfeeding medicine : the official journal of the Academy of Breastfeeding Medicine · 2024
    Article
  2. Article
  3. Gut microbiome and breast-feeding: Implications for early immune development.The Journal of allergy and clinical immunology · 2022
    Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. IgA Summons IgG to Take a Hit at HIV-1.Cell host & microbe · 2020
    Article
  10. Article
  11. Article
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 3 institutions in 2 countries.

Matthew Zirui TayDuke Human Vaccine Institute, Duke University, Durham, North Carolina, USA.
Erika L KunzDuke Human Vaccine Institute, Duke University, Durham, North Carolina, USA.
Aaron DealDuke Human Vaccine Institute, Duke University, Durham, North Carolina, USA.
Lu ZhangDuke Human Vaccine Institute, Duke University, Durham, North Carolina, USA.
Kelly E SeatonDuke Human Vaccine Institute, Duke University, Durham, North Carolina, USA.
Wes RountreeDuke Human Vaccine Institute, Duke University, Durham, North Carolina, USA.
Joshua A EudaileyDuke Human Vaccine Institute, Duke University, Durham, North Carolina, USA.
Jack HeptinstallDuke Human Vaccine Institute, Duke University, Durham, North Carolina, USA.
Michael D McRavenDepartment of Cell and Molecular Biology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.
Edgar MatiasDepartment of Cell and Molecular Biology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.
Erin McGuireDuke Human Vaccine Institute, Duke University, Durham, North Carolina, USA.
Nicole L YatesDuke Human Vaccine Institute, Duke University, Durham, North Carolina, USA.
Lautaro G PerezDuke Human Vaccine Institute, Duke University, Durham, North Carolina, USA.
David C MontefioriDuke Human Vaccine Institute, Duke University, Durham, North Carolina, USA.
R Glenn OvermanDuke Human Vaccine Institute, Duke University, Durham, North Carolina, USA.
Thomas J HopeDepartment of Cell and Molecular Biology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.ORCID 0000-0001-7183-8319
Xiaoying ShenDuke Human Vaccine Institute, Duke University, Durham, North Carolina, USA.ORCID 0000-0002-8387-3952
Linda KalilaniCollege of Medicine, University of Malawi, Blantyre, Malawi.
Genevieve G FoudaDuke Human Vaccine Institute, Duke University, Durham, North Carolina, USA.
Georgia D Tomaras *Duke Human Vaccine Institute, Duke University, Durham, North Carolina, USA gdt@duke.edu sallie.permar@dm.duke.edu.ORCID 0000-0001-8076-1931
Sallie R Permar *Duke Human Vaccine Institute, Duke University, Durham, North Carolina, USA gdt@duke.edu sallie.permar@dm.duke.edu.
Duke University · USNorthwestern University · USUniversity of Malawi · MW

Funding

LC: HIV Vaccine Trials NetworkUM1AI068618 · NIAID · FRED HUTCHINSON CANCER RESEARCH CENTER · PI Margaret Juliana McElrath · 2011 to 2026
$483.6M
Viral Sequencing CoreU19AI067854 · NIAID · DUKE UNIVERSITY · PI HAYNES, BARTON F. · 2006 to 2011
$290.5M
HVTN Laboratory ProgramU01AI068618 · NIAID · FRED HUTCHINSON CANCER RESEARCH CENTER · PI MCELRATH, MARGARET JULIANA · 2006 to 2010
$82.6M
Social and Behavioral Sciences CoreP30AI064518 · NIAID · DUKE UNIVERSITY · PI GEORGIA Doris TOMARAS · 2005 to 2026
$50.5M
Physical Resources CoreP01AI120756 · NIAID · DUKE UNIVERSITY · PI TOMARAS, GEORGIA DORIS · 2016 to 2020
$17.1M
Viral and Host Determinants of HIV-1 TransmissionU01AI067854 · NIAID · DUKE UNIVERSITY · PI COHEN, MYRON S · 2005 to 2005
$14.9M
Transmission-blocking potential of novel HIV Env-specific mucosal antibodiesR01AI106380 · NIAID · DUKE UNIVERSITY · PI PERMAR, SALLIE R. · 2013 to 2017
$3.4M
Innate antiviral factors in breast milk and the oral HIV-1 reservoirR01DE025444 · NIDCR · DUKE UNIVERSITY · PI GOSWAMI, RIA · 2015 to 2019
$3.1M
Role of neutralizing antibodies in HIV-1-infected and vaccinated mothers in MTCTR01AI122909 · NIAID · DUKE UNIVERSITY · PI KUMAR, AMIT · 2016 to 2019
$2.6M
NIAID NIH HHS P01 AI120756NIAID NIH HHS P30 AI064518NIAID NIH HHS R01 AI106380NIAID NIH HHS R01 AI122909NIAID NIH HHS U01 AI067854NIAID NIH HHS U01 AI068618NIAID NIH HHS U19 AI067854NIAID NIH HHS UM1 AI068618NIDCR NIH HHS R01 DE025444
6 · The paper itself

Abstract

The humoral response to invading mucosal pathogens comprises multiple antibody isotypes derived from systemic and mucosal compartments. To understand the contribution of each antibody isotype/source to the mucosal humoral response, parallel investigation of the specificities and functions of antibodies within and across isotypes and compartments is required. The role of IgA against HIV-1 is complex, with studies supporting a protective role as well as a role for serum IgA in blocking effector functions. Thus, we explored the fine specificity and function of IgA in both plasma and mucosal secretions important to infant HIV-1 infection, i.e., breast milk. IgA and IgG were isolated from milk and plasma from 20 HIV-1-infected lactating Malawian women. HIV-1 binding specificities, neutralization potency, inhibition of virus-epithelial cell binding, and antibody-mediated phagocytosis were measured. Fine-specificity mapping showed IgA and IgG responses to multiple HIV-1 Env epitopes, including conformational V1/V2 and linear V2, V3, and constant region 5 (C5). Env IgA was heterogeneous between the milk and systemic compartments (Env IgA, τ = 0.00 to 0.63,

Indexed as

AIDS VaccinesAntibodies, NeutralizingAntibody-Dependent Cell CytotoxicityAntibody FormationAntibody SpecificityCell LineCell Line, TumorEpitopesFemaleHEK293 CellsHIV-1HIV AntibodiesHIV InfectionsHT29 CellsHumansImmunoglobulin AAIDS VaccinesAntibodies, NeutralizingEpitopesHIV AntibodiesImmunoglobulin AImmunoglobulin Geffector functionsHIV-1IgAmucosal immunity

Identifiers

PMID30700599
PMCPMC6430545
OpenAlexW2914318358

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.